NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number

国药准字H20253231

Company江苏联环药业股份有限公司

Registration Date

January 24, 2025

Drug Information

Generic Name

奥美沙坦酯氨氯地平片

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg和苯磺酸氨氯地平5mg（以氨氯地平计）

Drug Type

化学药品

Registration Date

January 24, 2025

Company Information

Applicant Company

Company Name江苏联环药业股份有限公司

Company Address

江苏省扬州市扬州生物健康产业园健康一路9号

Manufacturing Company

Company Name江苏联环药业股份有限公司

Company Address

江苏省扬州市扬州生物健康产业园健康一路9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯氨氯地平片 - NMPA 批准文号 | MedPath